(What is Medxchange')
MedXchange is a blockchain-based system to democratize the global medical device industry. The platform will disintermediate the medical device and supplies ecosystem and make it more efficient. MedXchange comprises a platform to facilitate and secure the global exchange of medical devices, supplies and payments, lowering ultimate patient/customer or insurance cost and increasing efficiency. While the system will initially be focused on the medical device industry, it will be sufficiently flexible and scalable to add other categories of regulated health care ecosystems, such as pharmaceuticals, laboratory equipment, and services. Our platform is backed by proprietary, innovative use cases and real world businesses, in addition to our own proprietary cryptomining operations. Transactions on the system will be supported by MedCash (MEDCASH), an Etherium based (ERC-20) token used by users on the MedXchange platform as the exclusive cryptocurrency to conduct transactions, both in-country and globally.
(Why Medxchange')
The medical device industry is under major financial distress, in the United States but also globally. Many countries around the world are facing the same intensifying costs of medical devices and supplies and health care in general, as the United States and other countries are trying to address costs by reducing reimbursement rates, establishing price caps, requiring mandatory price reductions, using diagnostic related groups (DRGs), and limiting funds available for medical device purchases. With steeply increasing medical device costs, a secure solution for transparency and cost savings can have a massive impact on society.
(How Medxchange')
MedXchange seeks to facilitate and secure the global exchange of medical devices, supplies and payments. The system will democratize the $340 Billion global medical device industry (growing to $435 Billion in 2020) by disintermediating the medical device and supplies ecosystem and making it more efficient, lowering ultimate patient/user or insurance cost in the process. Because of the sensitive nature and requirements of medical devices, existing blockchain distributed systems are not adequate. The goal of MedXchange is to create a blockchain system that can pass the stringent requirements of regulated medical devices by ensuring better data integrity and encryption, and by providing a validation system to ensure the miners running this network are compliant entities.
MedXchange is a dual system platform utilizing a Blockchain protocol for transactions, identity and smart contracts, and with a distributed hash table (DHT) for data storage, managed by a governance system. The Blockchain protocol will be based off of the Ethereum network, and will start with proof of stake (i.e., Casper) and govern the data storage sites.
Most importantly, the system is backed by existing assets and use cases, including a novel, lifesaving medical technology that targets a population in excess of 835 million patients worldwide representing potentially in excess of 10 Billion transactions annually; a pipeline of additional, novel medical technologies and services companies targeted for acquisition also potentially representing billions of transactions annually; and our own proprietary cryptofarming operations in the works.
(What makes MedXchange/MedCash Unique')
First, MedXchange is not being created in a vacuum. MedXchange has existing agreements Sell-side medical device manufacturers. The use cases flowing from these include two proprietary medical devices that represent a potential universe of millions of Buy-side Users (end users / consumers) globally, representing a potential opportunity for Billions of transactions/payments annually using MedCash (MEDCASH) over a 10-year period.
Second, the token burning process over the next 3 years will be supported by our own proprietary cryptomining operations. We plan to scale up our current cryptomining operations dramatically to produce daily revenues immediately. These revenues will support the token burning process while the MedXchange platform is being developed.
(ICO Details')
Presale Start Date: March 16th, 2018
Presale End Date: March 31st, 2018
Token Symbol MEDCASH
Token Type ERC-20
Token Distribution: 55%: Sold; 15%: Team (on vesting schedules); 10%: CoSponsor/Use case provider; 1% Pre-white paper supporters; 4% Consultants (on vesting schedules); 5%: Technical tokens for stabilization and partnerships; 5%: Bounties; 5%:Further Development / Liquidity Reserve. In addition, the percentage of tokens the team has will remain at 15% regardless of how many tokens are burned.
Initial Token Price: $.50 USD per MEDCASH token
Minimum Purchase: $.10 USD
Hard Cap: 110,000,000 (110 Million) MEDCASH tokens – Equivalent to $55 million USD
Soft Cap: 10,000,000 (10 Million) MEDCASH tokens – Equivalent to $5 million USD
(Roadmap')
(Team and Partnerships')
Julian Ross, Founder/CEO (USA)
Edward Huntsberry, VP of Customer Acquisition (USA)
Alyssa Laurea, Creative Director (USA)
Sheryl Shea, Patient Relations (USA)
Giorgia Pellizzari, Business Development, Marketing, Project Management (Hong Kong)
Vadim Zolotokrylin, Programming, Business Development, Contributor (Hong Kong)
Chase Freeman, Programming, Smart Contracts, Advisor (USA)
Jonathan Martin, Advisor (UK)
Chris Kaplan, Advisor (USA)
Albert Deweese, Advisor (USA)
Robert Sanderson, Investor, Advisor (Canada)
Andrea (Zanini) Almeida, Legal Advisor
More Details Click Link Bellow:
Website: https://www.medxchange.io/
Whitepaper: https://www.medxchange.io/white-paper
Facebook: https://www.facebook.com/med.xchange.73
Twitter: https://twitter.com/medxchange1
Telegram: http://t.me/medcash
Author:Crypto Channel:( https://bitcointalk.org/index.php?action=profile;u=1153401 )
Mytherwallet: 0xf02df1350820ecc4C58BF067739900A50722D5Ca